Table 9.
Oxidative status: MDA, PCc, 8-OHdG
| T0 | SD | T1 | SD | p value | △ % | |||
|---|---|---|---|---|---|---|---|---|
| MDA URINE (μmol/ml) | ATHL | 0.030 | 0.017 | 0.019 | 0.011 | 0.02 | 36.67 | T1vsT0 |
| SED | 0.016 | 0.02 | 0.017 | 0.011 | 0.45 | 5.88 | T1vsT0 | |
| 0.10 | 46.67 | T0 | ||||||
| 0.70 | 10.53 | T1 | ||||||
| MDA BASAL PLASMA (μmol/ml) | ATHL | 0.026 | 0.015 | 0.002 | 0.002 | 1*10−6 | 90.59 | T1vsT0 |
| SED | 0.003 | 0.002 | 0.001 | 0.001 | 0.01 | 58.82 | T1vsT0 | |
| 6*10−4 | 86.67 | T0 | ||||||
| 0.30 | 41.67 | T1 | ||||||
| MDA STIMULATED PLASMA (μmol/ml) | ATHL | 0.053 | 0.017 | 0.016 | 0.003 | 7.0*10−8 | 69.19 | T1vsT0 |
| SED | 0.018 | 0.002 | 0.015 | 0.002 | 1*10−3 | 18.03 | T1vsT0 | |
| 2.7*10−5 | 65.41 | T0 | ||||||
| 0.30 | 7.98 | T1 | ||||||
| PCc (nmol/mg) | ATHL | 3.83 | 2.85 | 3.73 | 2.32 | 0.92 | 2.71 | T1vsT0 |
| SED | 3.50 | 2.12 | 5.31 | 1.61 | 0.1 | 34.01 | T1vsT0 | |
| 0.76 | 8.61 | T0 | ||||||
| 0.09 | 29.75 | T1 | ||||||
| 8-OHdG (ng/ml) | ATHL | 27.87 | 22.50 | 56.47 | 45.60 | 0.11 | 50.65 | T1vsT0 |
| SED | 73.77 | 75.00 | 67.32 | 63.90 | 0.87 | 8.74 | T1vsT0 | |
| 0.2 | 62.36 | T0 | ||||||
| 0.72 | 16.12 | T1 |
Data are expressed as mean values ± SD comparing two groups and two periods. Statistical analysis: repeated measures analysis of variance; level of significance: p < 0.05;△ % for the difference between mean values, T1vs T0 intra-group, Sedentary (SED) vs Athlete (ATHL) groups for T0 and T1